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Summary
Background:  Arterial  hypertension  is  an  established  risk  factor  for  acute  coronary  syndrome
(ACS). Multidetector  computed  tomography  (MDCT)  is  an  accurate  and  less  invasive  technique
for assessment  of  the  degree  of  coronary  artery  luminal  narrowing  and  characterization  of
coronary  atherosclerosis.  We  therefore  aimed  to  investigate  the  predictive  power  of  MDCT  for
future ACS  events  and  compared  with  traditional  parameters  in  patients  with  hypertension.
Methods: One  hundred  and  thirty-four  patients  (93  men,  mean  age  70  ±  11  years)  with  hyperten-
sion underwent  MDCT  for  evaluation  of  coronary  artery  disease.  MDCT  analysis  focused  on  the
presence  of  plaques,  the  degree  of  stenosis,  and  the  plaque  characteristics.  Traditional  param-
eters included  Framingham  risk  score,  carotid  intima-media  thickness,  and  left  ventricular  mass
index.
Results: During  a  mean  follow-up  of  39  ±  10  months,  ACS  events  occurred  in  10  patients,  includ-
ing myocardial  infarction  (n  =  3)  and  unstable  angina  (n  =  7).  Multivariate  analysis  identiﬁed  total
number of  low  attenuation  plaques  as  an  independent  predictor  of  ACS  events  (p  <  0.001).
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Conclusion:  We  demonstrated  that  non-obstructive  low  attenuation  coronary  plaques  on  MDCT
predicted  more  accurately  future  ACS  events  in  patients  with  hypertension  than  traditional
ardiology.  Published  by  Elsevier  Ltd.  All  rights  reserved.
I
A
v
d
l
e
c
s
i
c
i
t
o
h
l
p
c
c
r
v
a
h
c
C
t
o
c
t
d
e
o
e
i
n
A
p
c
M
S
T
h
f
s
t
a
a
w
1
w
e
ﬁbrillation  were  excluded  due  to  uninterpretable  datasets.
Thus,  the  ﬁnal  population  of  this  study  consisted  of  134
patients  (93  men,  mean  age  70  ±  11  years,  Fig.  1).  Patients
were  divided  into  a  primary  prevention  group  (n  =  77)  and  a
secondary  prevention  group  (n  =  57),  according  to  the  pres-
ence  or  absence  of  a  prior  history  of  CAD.  All  patients  were
followed  for  more  than  1  year  by  a  structured  or  telephone
interview  by  physicians.  This  study  was  approved  by  the
ethics  committee  of  the  Osaka  Ekisaikai  Hospital.
Scan  protocol  and  image  reconstruction
All  scans  were  performed  using  Somatom  Sensation  64
systems  (Siemens  Medical  System,  Forchheim,  Germany).
The  scan  parameters  were:  64  mm  ×  0.6  mm  collimation,
tube  voltage  120  kV,  gantry  rotation  time  330  ms,  and
tube  current  rotation  time  770—850  mAs.  The  estimated
radiation  dose  ranged  from  13  to  20  mSv.  For  the  contrast-
enhanced  scans  50—80  ml  of  nonionic  contrast  agent
(Omnipaque350,  Daiichi  Sankyo  Co.,  Tokyo,  Japan)  was
injected  intravenously  at  a  ﬂow  rate  of  3.5—5.5  ml/s  fol-
lowed  by  30  ml  of  saline.  Delay  time  was  deﬁned  using
the  bolus  tracking  technique  with  a  region  of  interest
positioned  at  the  level  of  the  ascending  aorta  in  the
monitoring  scan  and  using  manual  triggered  threshold  of
100  Hounsﬁeld  Units  (HU)  for  the  main  scanning.  All
scans  were  performed  during  a  single  breath  hold.  The
raw  data  were  reconstructed  using  algorithms  optimized
for  electrocardiogram-gated  multislice  spiral  reconstruc-
tion.
Figure  1  Schematic  ﬂow  diagram  of  patient  selection  appliedparameters.
© 2012  Japanese  College  of  C
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rterial  hypertension  leads  to  progressive  changes  in  left
entricular  (LV)  size  and  function,  and  vascular  endothelial
ysfunction  due  to  sustained  pressure  load,  with  increased
ong-term  cardiovascular  risk  and  mortality.  Several  param-
ters  are  widely  used  in  the  global  risk  assessment  for
oronary  artery  disease  (CAD)  [e.g.  the  Framingham  risk
core,  carotid  intima-media  thickness  (IMT),  and  LV  mass
ndex]  [1—3], but  they  have  limited  value  in  predicting  acute
oronary  syndrome  (ACS)  events  [4—6]. Accordingly,  there
s  a  need  for  more  accurate  diagnostic  tools  for  ACS  predic-
ion,  which  should  help  clarify  the  pathogenic  mechanisms
f  ACS  in  patients  with  hypertension  as  well  as  to  identify  the
igh-risk  patients  requiring  more  aggressive  intervention.
It  is  well  recognized  that  ACS  frequently  arises  from
esions  with  only  mild  to  moderate  stenosis,  and  the  cul-
rit  plaque  often  comprises  a  large  amount  of  necrotic
ore  with  an  overlying  thin  ﬁbrous  cap  (referred  to  as  thin
ap  ﬁbroatheroma)  [7,8]. Multidetector  computed  tomog-
aphy  (MDCT)  is  an  accurate  and  less  invasive  technique  for
isualizing  the  degree  of  luminal  narrowing  as  well  as  char-
cterizing  coronary  atherosclerosis  [9—11]. Previous  reports
ave  demonstrated  the  usefulness  of  MDCT  in  predicting
ardiovascular  events  in  patients  with  known  or  suspected
AD  [12—14]. However,  the  majority  of  the  past  investiga-
ions  included  patients  with  severe  coronary  artery  stenosis
n  MDCT  at  the  time  of  enrollment,  which  is  frequently
onsidered  an  indication  of  early  coronary  revasculariza-
ion  in  clinical  practice.  This  study  therefore  aimed  to
etect  the  high-risk  hypertensive  patients  developing  ACS
vents,  using  MDCT,  and  to  compare  the  predictive  power
f  MDCT  for  future  ACS  events  to  that  of  traditional  param-
ters  (e.g.  Framingham  risk  score,  IMT,  and  LV  mass  index)
n  patients  with  hypertension.  To  determine  whether  the
on-obstructive  coronary  plaque  on  MDCT  offers  a  better
CS  prediction  in  patients  with  hypertension,  we  excluded
atients  with  severe  coronary  stenosis  on  MDCT  requiring
oronary  revascularization.
ethods
tudy  population
he  study  patients  were  316  consecutive  patients  with
ypertension  who  were  scheduled  for  MDCT  examination
or  the  evaluation  of  known  or  suspected  CAD.  Hyperten-
ion  was  deﬁned  as  blood  pressure  more  than  or  equal
o  140/90  mmHg  on  repeated  measurements,  or  taking  an
ntihypertensive  medication  [15]. Fifty-four  patients  with
 history  of  coronary  artery  bypass  grafting,  and  5  patients
ith  hemodialysis  were  excluded.  After  MDCT  examination,
21  patients  who  underwent  coronary  revascularization
ithin  1  month  based  on  the  ﬁndings  of  MDCT  were  also
xcluded  from  the  analysis.  Also,  2  patients  who  had  atrial
in the  present  study.  CABG,  coronary  artery  bypass  grafting;
CAD, coronary  artery  disease;  MDCT,  multidetector  computed
tomography;  MI,  myocardial  infarction;  PCI,  percutaneous  coro-
nary intervention.
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MDCT  data  analysis
All  investigations  were  analyzed  by  a  single  experienced
reader,  blinded  to  all  clinical  variables,  history,  and  patients
demographics.  The  coronary  arteries  were  divided  into  16
separate  segments  that  were  1.5  mm  or  more  in  diameter
as  measured  on  the  MDCT  angiogram,  based  on  a  modi-
ﬁed  American  Heart  Association  classiﬁcation  [16]. Coronary
plaques  were  visually  evaluated  on  axial  images  and  curved
multiplanar  reconstruction  images.  In  each  coronary  artery
segment,  structures  >1  mm2 within  and/or  adjacent  to  the
coronary  artery  lumen,  which  could  be  clearly  distinguished
from  the  vessel  lumen  and  the  surrounding  pericardial  tis-
sue,  were  regarded  as  plaques  [17]. The  following  MDCT
parameters  were  then  assessed:
(1)  The  plaque  type  was  classiﬁed  into  the  following  3  types:
(i)  non-calciﬁed  plaques,  plaques  having  lower  den-
sity  compared  with  the  contrast-enhanced  vessel  lumen
without  any  visible  calciﬁcation;  (ii)  calciﬁed  plaques,
plaques  with  predominantly  high  density;  and  (iii)  mixed
plaques,  plaques  with  non-calciﬁed  and  calciﬁed  ele-
ments  within  a  single  plaque  [13].
(2) The  severity  of  stenosis  of  the  coronary  arteries  was
quantiﬁed  by  comparison  against  the  reference  vessel
diameter  without  plaque,  and  then  divided  into  obstruc-
tive  (≥50%  diameter  reduction)  or  non-obstructive
(<50%  diameter  reduction).
(3) To  identify  the  presence  of  low  attenuation  plaque
(LAP),  a  region  of  interest  was  placed  on  at  least  5
randomly  selected  points  within  each  plaque.  The  low-
est  density  was  deﬁned  as  the  plaque  density.  LAP  was
deﬁned  when  the  plaque  density  was  less  than  40  HU
[18].
(4)  The  ratio  of  vessel  diameter  at  the  plaque  site  to
the  reference  segment  set  proximal  to  the  lesion  in  a
normal-appearing  vessel  segment  was  evaluated,  and
positive  remodeling  (PR)  was  deﬁned  if  it  was  larger  than
1.10  [14,19].
For  each  patient,  the  number  of  segments  with  plaques,
with  obstructive  or  non-obstructive  plaques,  of  each  type  of
plaque,  of  LAP,  with  PR  was  calculated.  Patients  without  any
coronary  plaques  on  MDCT  were  considered  to  have  normal
coronary  artery;  an  abnormal  coronary  artery  was  deﬁned
as  the  presence  of  ≥1  coronary  plaque.
For  the  reduction  of  motion  artifacts  due  to  high  heart
rate  or  arrhythmias,  we  used  beta-blocker  (bisoprolol  5  mg)
2  h  before  MDCT  scans.  As  a  result,  mean  heart  rate  was  58
beats  per  minute  at  the  CT  scan,  and  heart  rate  <65  bpm
was  achieved  in  84%  of  patients.  However,  2  patients  who
had  atrial  ﬁbrillation  were  excluded  due  to  uninterpretable
datasets.  All  segments  with  stents  were  excluded  from
the  analysis.  Finally,  119  plaques  had  calciﬁcations  in  this
study.  However,  image  quality  in  these  calciﬁed  plaques  was
enough  to  assess  the  above-mentioned  semi-quantitative
parameters.Other  parameters
The  presence  or  absence  of  the  following  ACS  risk  fac-
tors  was  evaluated  based  on  data  retrieved  from  the
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edical  records:  hypercholesterolemia  (serum  total  choles-
erol  level  ≥  200  mg/dl,  or  statin  treatment)  [20], diabetes
fasting  plasma  glucose  level  >  126  mg/dl,  taking  hypo-
lycemic  drugs  or  insulin,  or  a  combination  of  the  two)  [21],
nd  smoking  in  each  patient.  For  each  subject,  a  Fram-
ngham  risk  score  was  calculated  assigning  gender-speciﬁc
oints  for  age,  smoking,  diabetes,  blood  pressure,  low-
ensity  lipoprotein  cholesterol  and  high-density  lipoprotein
holesterol  [1].
Carotid  ultrasound  examination  was  also  performed  to
easure  IMT.  IMT  was  measured  carefully  in  accordance  with
he  Rotterdam  Study  ultrasound  protocol  [2].  The  beginning
f  the  dilatation  of  the  distal  common  carotid  artery  served
s  a  reference  point  for  the  start  of  the  measurement.  The
verage  of  the  IMT  of  each  of  the  three  frozen  images  was
alculated.  For  each  individual,  IMT  was  determined  as  the
verage  of  near-  and  far-wall  measurements  of  both  the  left
nd  right  common  carotid  arteries.
LV  mass  was  measured  by  using  MDCT.  Manual  planime-
ry  of  the  endocardial  and  epicardial  LV  borders  (to  deﬁne
he  LV  myocardial  area)  was  performed  at  end-diastole,  on
hort-  and  long-axis  images.  LV  volume  was  calculated  by
 modiﬁed  Simpson’s  method,  in  which  the  sum  of  cross-
ectional  area  was  multiplied  by  the  sum  of  slice  thickness.
V  papillary  muscles  were  excluded  from  the  mass  measure-
ent.  The  LV  mass  was  calculated  by  the  following  formula:
.05  g/ml  × LV volume,  and  LV  mass  was  indexed  for  body
urface  area  [22].
ndpoints
he  endpoint  of  this  analysis  was  myocardial  infarction  and
nstable  angina  pectoris  requiring  hospitalization.  Myocar-
ial  infarction  was  deﬁned  based  on  the  criteria  of  typical
hest  pain,  elevated  cardiac  enzyme  levels,  and  typical
hanges  on  the  electrocardiogram  [23]. Unstable  angina  pec-
oris  was  deﬁned  based  on  the  criteria  of  the  American
ollege  of  Cardiology/American  Heart  Association  guidelines
24].  Angiographic  restenosis  incidentally  found  by  routine
ollow-up  coronary  angiography  without  clinical  symptoms
as  excluded  from  ACS  events.
tatistical  analyses
ategorical  variables  are  presented  as  frequencies  and  con-
inuous  variables  as  mean  ±  SD.  Variables  were  compared
ith  chi-square  statistic  for  categorical  variables  and  by  Stu-
ent’s  unpaired  t  test  for  continuous  variables.  A  composite
ndpoint  of  myocardial  infarction  and  unstable  angina  pec-
oris  was  used.  First,  univariate  analysis  of  baseline  clinical
haracteristics  and  MDCT  variables  was  performed  to  iden-
ify  potential  predictors  of  future  ACS  events.  To  determine
ndependent  predictors  of  the  composite  endpoint,  the  sig-
iﬁcant  variables  on  univariate  analysis  were  entered  into
ultivariate  stepwise  logistic  regression  analysis.  Hazard
atios  were  calculated  with  95%  conﬁdence  intervals  as  an
stimate  of  the  risk  associated  with  a  particular  variable.  To
dentify  the  association  between  MDCT  variables  and  out-
omes,  Kaplan—Meier  method  was  used.  Event  curves  of  the
omposite  endpoint  were  compared  using  the  log-rank  test.
ifferences  were  considered  signiﬁcant  at  p  <  0.05.
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Table  1  Comparison  of  clinical  characteristics,  laboratory  data,  and  traditional  parameters  between  patients  with  and  without
ACS events.
All  patients  (n  =  134)  Event  (+)  (n  =  10)  Event  (−)  (n  =  124)  p-value
Age,  years  70  ±  11  68  ±  15  70  ±  11  0.6
Male gender,  n  (%)  93  (69)  6  (60)  87  (70)  0.5
Systolic blood  pressure,  mmHg  129  ±  22  130  ±  28  129  ±  21  0.9
Diastolic blood  pressure,  mmHg  64  ±  10  67  ±  8  64  ±  10  0.3
Body mass  index  24.4  ±  4.0  23.4  ±  2.4  24.4  ±  4.0  0.4
Diabetes, n  (%) 45  (34)  6  (60)  39  (31)  0.07
Hypercholesterolemia,  n  (%) 87  (65) 9  (90)  78  (63)  0.09
Smoking, n  (%) 34  (25) 2  (20) 32  (26) 0.7
Previous history  of  MI,  n  (%) 30  (22) 6  (60) 24  (19) 0.003
Previous history  of  percutaneous
coronary  intervention,  n  (%)
57  (43) 7  (70) 50  (40) 0.07
Medications
Aspirin, n  (%)  85  (63)  10  (100)  75  (60)  0.02
ACEI or  ARB,  n  (%)  96  (72)  7  (70)  89  (72)  0.5
Beta-blockers,  n  (%)  41  (31)  4  (40)  37  (30)  0.09
Calcium channel  blockers,  n  (%)  62  (47)  1  (10)  61  (50)  0.02
Statin, n  (%)  69  (51)  8  (80)  61  (49)  0.07
Laboratory data
Hemoglobin,  g/dl  13.5  ±  1.6  13.1  ±  1.7  13.5  ±  1.6  0.4
eGFR, ml/min/1.73  m2 67  ±  13  65  ±  13  67  ±  13  0.7
LDL-cholesterol,  mg/dl  111  ±  34  110  ±  43  111  ±  33  0.9
HDL-cholesterol,  mg/dl  55  ±  16  53  ±  12  55  ±  16  0.7
Glucose, mg/dl  132  ±  57  162  ±  100  130  ±  51  0.09
Hemoglobin  A1c,  %  6.3  ±  1.5  6.5  ±  1.6  6.3  ±  1.5  0.7
C-reactive protein,  mg/dl  0.16  ±  0.20  0.24  ±  0.27  0.16  ±  0.19  0.3
Framingham  risk  score  7.6  ±  3.5  8.5  ±  4.7  7.5  ±  3.4  0.4
IMT, mm  0.9  ±  0.3  1.0  ±  0.7  0.8  ±  0.2  0.07
LV mass  index,  g/BSA  90.4  ±  19.7  89.9  ±  12.7  90.4  ±  20.3  0.9
Ejection fraction,  %  60.6  ±  8.3  55.7  ±  10.0  61.0  ±  8.1  0.05
Values are mean ± SD. ACEI, angiotensin-converting enzyme inhibitor; ACS, acute coronary syndrome; ARB, angiotensin receptor blocker;
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sBSA, body surface area; eGFR, estimated glomerular ﬁltration ra
low-density lipoprotein; LV, left ventricle; MI, myocardial infarcti
To  clarify  the  objectivity  in  MDCT  assessment,  we
xamined  the  inter-  and  intra-observer  variabilities.  Inter-
bserver  variability  for  MDCT  measurements  was  analyzed  in
0  random  subjects  by  two  independent  blinded  observers.
ntra-observer  variability  was  analyzed  in  another  group  of
0  subjects  by  the  same  observer  at  two  different  time
oints.
esults
uring  a  mean  follow-up  of  39  ±  10  months  ranging  from  12
onths  to  4.2  years  (median  3.2  years),  ACS  events  occurred
n  10  patients  (7.4%),  including  myocardial  infarction  in
 patients  and  unstable  angina  pectoris  in  7  patients.  All
atients  were  admitted  to  the  hospital,  and  8  patients
nderwent  percutaneous  coronary  intervention.  In  the
emaining  2  patients,  1  patient  developed  acute  myocardial
nfarction,  but  the  angiography  showed  a  vessel  diameter
oo  small  to  be  treated  with  coronary  revascularization.
he  other  patient  developed  unstable  angina  pectoris,  but
eceived  infusion  and  oral  medication  treatment  due  to  poor
eneral  status.  Table  1  summarizes  the  baseline  patient
haracteristics.  Patients  with  ACS  events  had  a  higher
m
t
mDL, high-density lipoprotein; IMT, intima-media thickness; LDL,
revalence  of  a  history  of  myocardial  infarction,  took
spirin,  and  were  less  likely  to  be  on  a  calcium-channel
locker.  The  results  of  traditional  ACS  risk  factors  and  lab-
ratory  data  are  also  listed  in  Table  1.  There  were  no
igniﬁcant  differences  between  the  ACS  events-positive  and
negative  groups  with  respect  to  the  Framingham  risk  score,
MT,  LV  mass  index,  and  any  of  the  laboratory  parameters.
Univariate  analysis  showed  signiﬁcantly  higher  numbers
f  total  plaques,  plaques  in  the  left  anterior  descending
LAD)  artery,  plaques  in  the  left  circumﬂex  (LCX)  artery,
otal  obstructive  plaques,  non-obstructive  LAD  plaques,
on-obstructive  LCX  plaques,  mixed  plaques,  total  LAP,  LAP
n  LAD,  and  LAP  in  LCX,  LAD  plaques  with  PR  and  total
laques  with  PR  in  patients  with  ACS  events  compared
o  those  without  events  (Table  2).  All  signiﬁcant  clinical
nd  MDCT  parameters  on  the  univariate  analysis  were  then
ntered  into  the  multivariate  analysis.  The  number  of  total
AP  (p  <  0.001)  was  identiﬁed  by  multivariate  analysis  as  a
igniﬁcant  and  independent  predictor  of  ACS  events.ACS  events  were  observed  in  3  (3.9%)  patients  in  the  pri-
ary  prevention  group  (n  =  77),  and  in  7  (12.3%)  patients  in
he  secondary  prevention  group  (n  =  57)  (p  =  0.07).  In  the  pri-
ary  prevention  group,  patients  with  ACS  events  had  larger
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Table  2  Number  of  plaques  in  patients  with  and  without  ACS  events.
All  patients  Event  (+)  Event  (−)  p-value
Total  plaques  2.3  ±  1.8  4.1  ±  2.1  2.1  ±  1.7  0.003
Obstructive  plaques  0.5  ±  0.9  1.3  ±  1.4  0.5  ±  0.8  0.004
Non-obstructive  plaques  1.5  ±  1.4  2.2  ±  1.5  1.5  ±  1.4  0.1
LMCA plaques  0.04  ±  0.21  0.10  ±  0.32  0.04  ±  0.20  0.4
LAD plaques 1.0  ±  0.9  1.9  ±  0.7  1.0  ±  0.9  0.006
Non-obstructive  LAD  plaques 0.8 ±  0.8  1.5 ±  0.7  0.7 ±  0.8  0.002
LCX plaques 0.5 ±  0.7  1.1 ±  1.0  0.5 ±  0.6  0.007
Non-obstructive  LCX  plaques 0.4 ±  0.6  0.8 ±  0.9  0.3 ±  0.6  0.003
RCA plaques  0.6  ±  0.8  0.9  ±  1.0  0.6  ±  0.7  0.2
Non-obstructive  RCA  plaques  0.5  ±  0.7  0.4  ±  0.8  0.5  ±  0.7  0.7
Non-calciﬁed  plaques  1.2  ±  1.2  1.8  ±  1.5  1.2  ±  1.2  0.1
Mixed plaques 0.4  ±  0.7  0.8  ±  1.0  0.4  ±  0.7  0.05
Calciﬁed plaques  0.5  ±  1.0  1.0  ±  1.2  0.5  ±  0.9  0.09
Total LAP  0.4  ±  0.7  1.2  ±  1.0  0.3  ±  0.6  <0.001
LAP in  LAD  0.2  ±  0.4  0.6  ±  0.8  0.1  ±  0.4  <0.001
LAP in  LCX  0.1  ±  0.2  0.2  ±  0.4  0.04  ±  0.20  0.03
LAP in  RCA  0.1  ±  0.3  0.3  ±  0.5  0.1  ±  0.3  0.09
Total plaques  with  PR  0.2  ±  0.4  0.7  ±  0.8  0.2  ±  0.4  <0.001
Plaques with  PR  in  LAD 0.1  ±  0.3  0.4  ±  0.7  0.1  ±  0.3  0.005
Plaques with  PR  in  LCX  0.03  ±  0.17  0.10  ±  0.32  0.02  ±  0.15  0.2
Plaques with  PR  in  RCA 0.1  ±  0.3  0.2  ±  0.4  0.1  ±  0.2  0.1
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1Values are mean ± SD. ACS, acute coronary syndrome; LAD, left an
left circumﬂex coronary artery; LMCA, left main coronary artery; 
number  of  plaques  in  LAD,  mixed  plaques,  total  LAP,  LAP
in  LAD,  total  plaques  with  PR,  plaques  with  PR  in  LAD,  and
plaques  with  PR  in  right  coronary  artery  (RCA)  than  those
without  ACS  events  (Table  3).  When  these  parameters  were
entered  into  the  multivariate  analysis,  the  number  of  LAP  in
LAD  was  the  independent  risk  factor  for  future  ACS  events
(p  =  0.04).  In  the  secondary  prevention  group  (n  =  57),  there
were  signiﬁcant  differences  in  the  number  of  plaques  in
LCX  (p  =  0.03),  total  obstructive  plaques  (p  =  0.03),  total  LAP
(p  =  0.04),  and  LAP  in  RCA  (p  =  0.001)  between  patients  with
and  without  ACS  events.  However,  these  signiﬁcant  parame-
ters  on  the  univariate  analysis  turned  out  to  be  insigniﬁcant
on  the  multivariate  analysis.
p
e
Figure  2  Kaplan—Meier  curves  for  ACS  events  based  on  the  numb
(B). *p  <  0.001,  compared  with  LAP  =  0.  ACS,  acute  coronary  syndrome
tomography.r descending coronary artery; LAP, low attenuation plaque; LCX,
 right coronary artery; PR, positive remodeling.
Fig. 2A  demonstrates  the  Kaplan—Meier  curves  for  time
o  ACS  events  according  to  the  number  of  LAPs.  Increased
vent  rates  were  observed  in  patients  with  ≥2  LAP  compared
ith  those  without  LAP  (p  <  0.001).  No  ACS  events  occurred
n  patients  with  no  plaque  on  MDCT,  whereas  3-year  ACS
vent  rate  of  9.3%  was  observed  in  patients  with  plaques  on
DCT  (p  =  0.11,  Fig.  2B).
The  culprit  lesion  of  cardiac  events  corresponded  with
he  LAP  site  in  7  (70%)  of  10  patients.  In  the  other  3  patients,
he  culprit  lesions  were  obstructive  calciﬁed  plaque  in
 patient,  non-obstructive  and  non-calciﬁed  plaque  in  1
atient,  and  non-obstructive  mixed  plaque  in  1  patient.  Case
xamples  are  presented  in  Fig.  3.
er  of  LAP  on  MDCT  (A)  and  normal/abnormal  coronary  arteries
;  LAP,  low  attenuation  plaque;  MDCT,  multidetector  computed
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Table  3  Number  of  plaques  with  and  without  ACS  events  in  primary  prevention  patients.
All  patients  (n  =  77)  Event  (+)  (n  =  3)  Event  (−)  (n  =  74)  p-value
Total  plaques  1.6  ±  1.6  3.3  ±  1.2  1.6  ±  1.5  0.05
Obstructive  plaques  0.4  ±  0.8  1.0  ±  1.0  0.4  ±  0.8  0.2
Non-obstructive  plaques  1.1  ±  1.4  2.0  ±  2.0  1.1  ±  1.3  0.3
LMCA plaques  0.08  ±  0.27  0.33  ±  0.58  0.07  ±  0.25  0.09
LAD plaques  0.8  ±  0.8  2.0  ±  1.0  0.8  ±  0.8  0.01
Non-obstructive  LAD  plaques 0.6  ±  0.8  1.3  ±  1.2  0.5  ±  0.7  0.07
LCX plaques 0.3  ±  0.5 0.3  ±  0.6  0.3  ±  0.5  0.9
Non-obstructive  LCX  plaques 0.2  ±  0.5 0.0  ±  0.0 0.2  ±  0.5  0.5
RCA plaques 0.4  ±  0.6 0.7  ±  1.2 0.4  ±  0.6 0.5
Non-obstructive  RCA  plaques 0.4  ±  0.6 0.7  ±  1.2 0.4  ±  0.6 0.4
Non-calciﬁed  plaques  1.1  ±  1.1  1.7  ±  0.6  1.0  ±  1.2  0.4
Mixed plaques  0.3  ±  0.6  1.0  ±  1.0  0.2  ±  0.5  0.03
Calciﬁed plaques  0.3  ±  0.8  0.7  ±  0.6  0.3  ±  0.8  0.4
Total LAP  0.3  ±  0.6  1.7  ±  0.6  0.05  ±  0.23  <0.001
LAP in  LAD  0.2  ±  0.4  1.3  ±  0.6  0.1  ±  0.4  <0.001
LAP in  LCX  0.03  ±  0.16  0.0  ±  0.0  0.03  ±  0.16  0.8
LAP in  RCA  0.06  ±  0.25  0.3  ±  0.6  0.05  ±  0.23  0.06
Total plaques  with  PR  0.2  ±  0.4  1.0  ±  1.0  0.1  ±  0.3  <0.001
Plaques with  PR  in  LAD  0.1  ±  0.3  0.7  ±  0.6  0.1  ±  0.3  0.002
Plaques with  PR  in  LCX  None  None  None  —
Plaques with  PR  in  RCA  0.05  ±  0.22  0.3  ±  0.6  0.04  ±  0.20  0.02
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eValues are mean ± SD. ACS, acute coronary syndrome; LAD, left a
left circumﬂex coronary artery; LMCA, left main coronary artery;
Excellent  correlation  was  observed  in  inter-observer  and
ntra-observer  variability  of  MDCT  measurements.  Values
ere    =  1.0  and    =  0.93  for  plaque  type,    =  1.0  and    =  0.80
or  stenosis  severity,  r  =  0.95  and  r  =  0.92  for  plaque  density,
nd  r  =  0.98  and  r  =  0.97  for  LV  mass  index,  respectively.
iscussion
he  present  study  demonstrated  for  the  ﬁrst  time  that  MDCT
ad  the  advantage  over  various  traditional  parameters  (e.g.
ramingham  risk  score,  IMT,  and  LV  mass  index)  in  predicting
-year  ACS  events  in  patients  with  hypertension  and  free  of
evere  coronary  stenosis  requiring  coronary  revasculariza-
ion.
Hypertension  is  an  established  risk  factor  for  ACS  events.
t  is  therefore  important  to  accurately  diagnose  cardiovas-
ular  events  in  patients  with  hypertension,  especially  ACS
vents.  Recent  studies  have  provided  pathophysiological
nsights  into  the  cause  of  ACS,  disruption  of  atheroscle-
otic  plaques.  These  plaques  often  cause  mild  to  moderate
tenosis,  characterized  histopathologically  by  large  plaque
olumes  and  large  necrotic  cores  covered  with  thin  ﬁbrous
ap,  and  are  responsible  for  at  least  two-thirds  of  the  ACS
vents  [7,8]. Several  parameters  are  used  for  the  predic-
ion  of  ACS  events  in  patients  with  hypertension  such  as
ramingham  risk  score,  IMT,  and  LV  mass  index.  The  Fram-
ngham  risk  score  is  a  simple  coronary  disease  prediction
lgorithm  using  categorical  variables  of  clinical  risk  fac-
ors.  IMT  serves  as  a  marker  of  generalized  atherosclerosis
25],  and  LV  hypertrophy  is  the  earliest  manifestation  of
ardiac  damage  in  patients  with  hypertension  [22]. Unfortu-
ately,  the  accuracy  of  these  traditional  parameters  in  ACS
i
r
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tr descending coronary artery; LAP, low attenuation plaque; LCX,
ositive remodeling; RCA, right coronary artery.
rediction  is  often  unsatisfactory  to  account  for  most  ACS
vents  [4—6].
MDCT  is  currently  recognized  as  an  accurate  and  less
nvasive  technique  for  visualization  and  assessment  of  the
egree  of  coronary  luminal  narrowing  [9].  Recently,  MDCT
as  been  applied  for  the  assessment  of  prognosis  of  patients
ith  known  or  suspected  CAD.  Min  et  al.  [12]  concluded  that
tenosis  of  the  proximal  LAD  and  number  of  vessels  with
bstructive  plaques  on  MDCT  were  predictors  for  approx-
mately  1-year  all-cause  mortality.  Pundziute  et  al.  [13]
lso  showed  that  patients  with  obstructive  lesions  in  the
eft  main  coronary  artery  and  LAD  on  MDCT  had  greatest
isk  for  cardiac  events,  while  those  with  normal  coronary
n  MDCT  had  excellent  prognosis  during  a  mean  follow-up
f  16  months.  Furthermore,  Motoyama  et  al.  [14]  reported
hat  PR  or  the  existence  of  LAP  on  MDCT  was  an  indepen-
ent  predictor  of  ACS  events  for  a  2-year  follow-up  period.
owever,  there  is  no  or  little  information  on  ACS  predic-
ion  in  patients  with  hypertension  using  MDCT  or  comparison
f  the  prognostic  value  of  MDCT  with  traditional  parame-
ers.  More  importantly,  past  investigations  included  patients
ith  severe  coronary  artery  stenosis  on  MDCT  at  the  time
f  enrollment,  although  such  patients  are  generally  consid-
red  as  an  indication  of  early  coronary  revascularization.
he  patients  enrolled  in  the  present  study  included  patients
ho  did  not  have  severe  coronary  stenosis  requiring  coro-
ary  revascularization,  which  would  be  more  close  to  the
eal  clinical  situation.  The  results  showed  that  the  pres-
nce  of  non-obstructive  LAP  on  MDCT  was  associated  with
ncreased  likelihood  of  ACS  during  a  3-year  follow-up.  Theo-
etically,  these  non-obstructive  plaques  are  not  detectable
n  other  noninvasive  modalities,  such  as  exercise  elec-
rocardiography,  stress  single-photon  emission  computed
Prediction  of  ACS  events  by  MDCT  173
Figure  3  Examples  of  patients  with  ACS  after  MDCT  examinations.  Case  1:  curved  multiplanar  reconstruction  image  of  right
coronary artery  demonstrated  the  presence  of  LAP  (arrows)  (A).  The  same  segment  was  determined  in  the  culprit  lesion  based
on invasive  coronary  angiography  3  years  after  MDCT  examination  (B).  Case  2:  LAP  (arrows)  in  the  LAD  was  evident  in  curved
multiplanar reconstruction  image  of  MDCT  (C),  which  was  associated  with  ACS  15  months  after  MDCT  examination  (D).  ACS,  acute
coronary syndrome;  LAD,  left  anterior  descending  coronary  artery;  LAP,  low  attenuation  plaque;  MDCT,  multidetector  computed
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tomography,  or  stress  echocardiography,  each  of  which  is
designed  to  detect  myocardial  ischemia  [26,27].  In  this
regard,  invasive  catheter-based  techniques  (e.g.  intravas-
cular  ultrasound  and  optical  coherence  tomography)  have
been  used  to  identify  vulnerable  plaques  associated  with  ACS
events  [28—30]. With  advances  in  medical  electronic  tech-
nology,  MDCT  has  been  applied  as  a  less  invasive  technique,
for  the  detection  of  vulnerable  plaques  associated  with  the
development  of  ACS  events  [19,31,32]. By  visualizing  the
plaque  itself  directly,  MDCT  provides  more  accurate  diagnos-
tic  information,  which  allows  clariﬁcation  of  the  pathogenic
mechanisms  of  ACS  in  patients  with  hypertension  as  well
as  identiﬁcation  of  the  high-risk  group  requiring  aggressive
intervention,  such  as  high-intensity  statin  therapy  [33].
Study  limitations
Our  study  has  several  limitations.  First,  the  number  of
patients  included  was  relatively  small,  especially  in  the
secondary  prevention  group  (n  =  57).  Furthermore,  previous
large-scale  clinical  trials  have  showed  that  aspirin,  statin,
and  anti-hypertension  drugs,  such  as  angiotensin-converting
enzyme  inhibitors,  angiotensin  receptor  blockers,  and  beta-
blockers,  were  effective  for  prevention  of  cardiac  events
[34,35].  However,  these  parameters  were  insigniﬁcant  in  this
study.  Future  study  with  a  large  population  is  necessary  to
conﬁrm  the  results  of  this  study.
T
L
e
sSecond,  because  patients  with  hypertension  were
nrolled,  the  results  of  this  study  were  used  only  in  patients
ith  hypertension.  Also,  we  did  not  evaluate  the  type  of
ypertension  whether  dipper  or  non-dipper,  which  is  impor-
ant  because  nocturnal  hypertension  is  recognized  as  a
etter  predictor  of  cardiovascular  mortality  than  diurnal
lood  pressure  [36].
Third,  contrast-induced  nephropathy  may  have  occurred
articularly  in  patients  with  chronic  kidney  disease  [37].
lso,  high  radiation  dose  is  a  signiﬁcant  issue  for  MDCT,
herefore  the  reduction  of  radiation  dose  must  be  resolved.
on-helical  gantry  rotation  mode  or  prospective  gating  may
e  useful  to  reduce  the  exposure  to  1—3  mSv  [38,39].
Finally,  the  CT  density  of  LAP  ranged  from  30  to  50  HU
n  previous  reports,  there  is  no  ofﬁcial  decision  [17,19], and
he  CT  plaque  density  might  be  affected  by  various  factors
uch  as  the  lumen  density  of  the  contrast,  and  the  tube  volt-
ge  [40]. Furthermore,  the  impact  of  the  extent  and  location
f  coronary  artery  calciﬁcation  on  the  results  of  this  study
as  unclear  [28,41].
onclusionhis  is  the  ﬁrst  study  to  demonstrate  that  non-obstructive
AP  on  MDCT  are  associated  with  the  occurrence  of  ACS
vents  during  3-year  follow-up  in  patients  with  hyperten-
ion  and  are  a  more  powerful  predictor  than  traditional  risk
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